Tune Therapeutics raises $175M Series B for epigenetic editing, with hepatitis B drug Tune-401 in the clinic. NEA, Yosemite, ...
NeurIPS, the biggest AI research conference, turned Vancouver’s convention center into a battleground for wooing AI talent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback